FDA reviews evidence on peptide supplements amid rising demand

The U.S. Food and Drug Administration has raised concerns about the scientific evidence supporting a wave of dietary supplements that are being marketed for sleep enhancement, muscle growth and anti‑ageing benefits. The agency’s inquiry comes as consumer demand for these compounds has accelerated, driven by aggressive advertising and a growing wellness market that touts rapid results without clear clinical validation.

Regulators are reviewing the data submitted by manufacturers to determine whether the products meet safety and efficacy standards required for over‑the‑counter sales. The FDA’s scrutiny includes evaluating clinical trial results, adverse‑event reports and labeling claims to ensure they do not mislead consumers. Companies may be required to provide additional research, adjust marketing language or face enforcement actions if the evidence is deemed insufficient. The agency’s assessment aims to protect public health while clarifying the regulatory status of these popular supplements.